Metalloporphyrins and their uses as radiosensitizers for radiation therapy
Patent
·
OSTI ID:1174934
The present invention covers radiosensitizers containing as an active ingredient halogenated derivatives of boronated porphyrins containing multiple carborane cages having the structure ##STR1## which selectively accumulate in neoplastic tissue within the irradiation volume and thus can be used in cancer therapies including, but not limited to, boron neutron--capture therapy and photodynamic therapy. The present invention also covers methods for using these radiosensitizers in tumor imaging and cancer treatment.
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-98CH10886
- Assignee:
- Brookhaven Science Associates, LLC (Upton, NY)
- Patent Number(s):
- 6,759,403
- Application Number:
- 10/117,010
- OSTI ID:
- 1174934
- Country of Publication:
- United States
- Language:
- English
Similar Records
Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
Use of novel metalloporphyrins as imageable tumor-targeting agents for radiation therapy
Boronated porhyrins and methods for their use
Patent
·
2003
·
OSTI ID:1174335
Use of novel metalloporphyrins as imageable tumor-targeting agents for radiation therapy
Patent
·
2005
·
OSTI ID:1175518
Boronated porhyrins and methods for their use
Patent
·
1999
·
OSTI ID:872173